COMPANY
YEASEN BIOTECHNOLOGY (SHANGHAI) CO LTD
YEASEN BIOTECHNOLOGY (SHANGHAI) CO LTD: API manufacturer for Semaglutide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Semaglutide | DMF 44063, type II, active, submitted 2026-06-26 Regulator FDA drug master file list |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.